The ‘Global Bovine Respiratory Disease Treatment Market Size, Share, Price, Trends, Growth, Analysis, Report and Forecast 2022-2027’ by Expert Market Research gives an extensive outlook of the global bovine respiratory disease treatment market, assessing the market on the basis of its segments like disease type, drug type, end-use, and major regions.
Bovine Respiratory Disease Treatment Market Size, Share, Trends, Industry Report, Key Player, Major Segments, and Forecast
The key highlights of the report include:
Market Overview 2017-2027
• Forecast CAGR (2022-2027): 11.5%
The global bovine respiratory disease treatment market is anticipated to register significant growth on account of an upsurge in respiratory infections, along with a lack of drugs to treat specific pathogens, to reduce the mortality rates of animals. With the growing research on bovine respiratory disease and the increasing focus of key players on functional therapies, the market growth for bovine respiratory disease treatment is likely to be pushed forward due to huge investments in the field.
The growing cattle industry and rising demand for advanced and better treatment for bovine respiratory disease are likely to influence the market demand across the globe as advanced treatments are expected to be cost-effective and help to reduce the usage of antibiotics.
Moreover, the innovative technology is likely to detect three of the top four bacterial types including Pasteurella multocida, Mannheimia haemolytica, and Histophilus somni which caused bovine respiratory disease. These developments are expected to boost the global market growth for bovine respiratory disease treatment.
Bovine Respiratory Disease Treatment Industry Definition and Major Segments
The bovine respiratory disease complex is a primary cause of mortality and morbidity in feedlot cattle. This disease is called a multifactorial disorder caused by a blend of viral as well as bacterial pathogens together with environmental risk aspects. The bovine respiratory disease treatment incorporates the advice to utilise third-generation fluoroquinolones, cephalosporins, florfenicol, or tilmicosin, a macrolide antibiotic.
By disease type, the market is segmented into:
• Pneumonia (Lower Respiratory Tract Infections)
• Upper Respiratory Tract Infections
By drug type, the market is divided into:
• Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
By end-use, the market is classified into:
• Veterinary Hospitals
• Veterinary Clinics
Based on region, the market is divided into:
• North America
• Latin America
• Asia Pacific
• Middle East and Africa
Bovine Respiratory Disease Treatment Market Trends
On the basis of end-uses, the veterinary hospital segment is expected to gain momentum across the globe during the forecast period on account of the increasing cattle population, along with the high demand for a larger facility. The veterinary hospital has more veterinarians and other certified staff to care of emergency and overnight patients, which is further expected to boost the market growth globally over the upcoming years. Based on region, the North American region is witnessing considerable growth in the bovine respiratory disease treatment market on account of various aspects including a huge bovine animal pool, coupled with a growing incidence of bovine respiratory disease.
The surging expenditure on bovine health, coupled with the growing medical and health industry in the region, is aiding the market growth of bovine respiratory disease treatment in North America. Meanwhile, the Asia Pacific region is expected to register growth in the market for bovine respiratory disease treatment during the forecast period on account of the huge livestock animal husbandry along with the increasing prevalence of bovine disorders like bovine respiratory disease.
Increasing government initiatives toward bovine respiratory disease treatment and surging awareness regarding animal welfare are also expected to support the market growth across the Asia Pacific region over the coming years.
Key Market Players
The major players in the global bovine respiratory disease treatment market
• Boehringer Ingelheim International GmbH
• Elanco Animal Health Incorporated
• Zoetis Services LLC.
• Ceva Santé Animale
• Norbrook Group
The report covers the market shares, capacities, plant turnarounds, expansions, investments, and mergers and acquisitions, among other latest developments of these market players.
The report studies the latest updates in the market, along with their impact across the market. It also analysis the market demand, together with its price and demand indicators. The report also tracks the market on the bases of SWOT and Porter’s Five Forces Models.
Read More Reports:
Expert Market Research (EMR) is leading market research company with clients across the globe. Through comprehensive data collection and skilful analysis and interpretation of data, the company offers its clients extensive, latest, and actionable market intelligence which enables them to make informed and intelligent decisions and strengthen their position in the market. The clientele ranges from Fortune 1000 companies to small and medium scale enterprises.
EMR customises syndicated reports according to clients’ requirements and expectations. The company is active across over 15 prominent industry domains, including food and beverages, chemicals and materials, technology and media, consumer goods, packaging, agriculture, and pharmaceuticals, among others.
Over 3000 EMR consultants and more than 100 analysts work very hard to ensure that clients get only the most updated, relevant, accurate and actionable industry intelligence so that they may formulate informed, effective, and intelligent business strategies and ensure their leadership in the market.
Company Name: Claight Corporation
Contact Person: James Rowan, Business Consultant
Toll Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA